This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Fondazione Città Della Speranza—onlus, Università Degli Studi Dell'aquila. Active years: 2019-2021.
Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2019-2021
Title: Anna Maria Teti: Innovator in Therapeutic and Diagnostic Applications
Introduction
Anna Maria Teti is a prominent inventor based in L'Aquila, Italy. She has made significant contributions to the fields of therapeutic and diagnostic applications, particularly in bone pathologies. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
One of her latest patents is titled "Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use." This invention relates to RANKL+ cellular vesicles isolated from osteoblastic lineage cells, which can be used for the therapeutic treatment of bone pathologies and for diagnostic purposes. The processes for the production of these vesicles are also detailed in the patent. Another notable patent is "Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) autosomal dominant osteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation." This invention focuses on small interfering RNA molecules that have therapeutic applications, specifically in reducing gene expression in a highly specific manner.
Career Highlights
Throughout her career, Anna Maria Teti has worked with various organizations, including the Fondazione Città Della Speranza and the Università Degli Studi Dell'Aquila. Her research has significantly impacted the understanding and treatment of bone-related diseases.
Collaborations
Anna Maria has collaborated with notable colleagues such as Maurizio Muraca and Nadia Rucci. Their combined expertise has contributed to the advancement of her innovative work.
Conclusion
Anna Maria Teti stands out as a dedicated inventor whose work in therapeutic and diagnostic applications continues to influence the field of medicine. Her patents reflect her commitment to advancing healthcare solutions.